NIH-funded research Career grant

Understanding how lung immune cells affect COVID-19 lung damage

Official title: Novel animal models to dissect how lung macrophages contribute to SARS-CoV2 alveolar pathology and respiratory failure

Funded at Cornell University · NIH-10979157 · Data updated 2026-11-12

This study is looking at how certain immune cells might be hurting the lungs of people with severe COVID-19, and it's for anyone interested in understanding more about the virus and finding better ways to help patients breathe easier.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionCornell University
NIH-funded
Lab location1 site (Ithaca, United States)
Project startDecember 1, 2021
Project endNovember 30, 2026
Funding year2025
Award (this year)$138,267
NIH project number5K01OD031968-04
Project IDNIH-10979157 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have experienced severe respiratory issues or lung damage due to COVID-19.

Less likely to help

Patients who have not been infected with SARS-CoV2 or who do not exhibit respiratory complications from COVID-19 may not benefit from this research.

What this research studies

This research investigates the role of macrophages, a type of immune cell, in causing lung damage related to COVID-19. By using both human and mouse models, the researchers aim to develop new mouse models that can help identify how SARS-CoV2 affects lung cells. The study involves collaboration among experts in various fields, including lung biology and virology, to gain insights into the mechanisms of respiratory failure caused by the virus. The findings could lead to better understanding and treatment options for patients suffering from severe COVID-19 symptoms.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for lung damage caused by COVID-19.

How similar studies have gone: Other research has shown promise in understanding immune responses to viral infections, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Cornell University
    Ithaca, United States
    Active

Researchers

  • Principal investigator: Gludish, David W — Cornell University
  • Study coordinator: Gludish, David W

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.